Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
850.00    34.00 (4.17%)
Bid:
844.00
Ask:
852.00
Spread: 8.00 (0.948%)
Market Cap: £391.82m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close trading update

1 Dec 2014 07:00

RNS Number : 3904Y
Porvair PLC
01 December 2014
 



For immediate release 1 December 2014

 

 

 

Pre-close trading update

 

Porvair ("Porvair" or "the Group"), the specialist filtration and environmental technologies group, makes the following announcement regarding trading for the year ended 30 November 2014 ahead of its close period.

 

Porvair has continued to trade strongly throughout the year. Both divisions are expected to deliver record results, with revenue for the full year up 24% (28% at constant exchange rates) and earnings marginally ahead of current market expectations.

 

Strong operating cash flow has increased net cash at the year end to around £5m, achieved after capital investments of £5m, mostly spent on expanding manufacturing capacity to meet demand.

 

As anticipated in previous announcements, Group revenue in 2014 received a one-off boost of £20m (2013: £6m) from several large contracts, each of which is proceeding as expected. Profits on these contracts are recognised after making appropriate allowance for the outstanding liabilities, potential risks and warranties. Consequently, we expect further profits to be achieved as milestones are successfully passed over the period to 2017.

 

Revenue in the Microfiltration division was 34% (36% at constant exchange rates) ahead of the prior year. Underlying revenue growth, excluding the impact of the large projects mentioned above, was 9% (11% at constant exchange rates). Aerospace revenue continued to grow steadily and Seal Analytical recorded a record result for the year.

 

Revenue in the Metals Filtration division was 5% (11% at constant exchange rates) ahead of the prior year. Market share gains continued to be made, particularly in iron foundry filtration. The new plant in Wuhan, China, is performing as expected and revenue from aluminium filtration in China was strong.

 

The Group has adopted IAS19 Revised, Employee Benefits, in the year ended 30 November 2014. This increases the defined benefit pension scheme costs charged in the accounts and requires a revision of prior years. Earnings per share for the year ended 30 November 2013, the comparative period, are restated at 12.3 pence compared with the previously reported 12.7 pence.

 

Order books for the start of 2015 are healthy and the Group has a promising pipeline of potential projects.

 

Porvair will announce its preliminary results for the year ended 30 November 2014 on Monday 26 January 2015.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFLZFFLFBK
Date   Source Headline
7th Apr 20097:00 amRNSAGM/Interim Management Stmt
20th Mar 20095:30 pmRNSHolding(s) in Company
16th Feb 20093:27 pmRNSHolding(s) in Company
3rd Feb 20093:31 pmRNSHolding(s) in Company
3rd Feb 20093:13 pmRNSHolding(s) in Company
2nd Feb 20094:40 pmRNSHolding(s) in Company
2nd Feb 20094:29 pmRNSHolding(s) in Company
27th Jan 20097:00 amRNSPreliminary Results
21st Jan 200910:50 amRNSHolding(s) in Company
10th Dec 20087:00 amRNSTrading update
2nd Dec 20082:54 pmRNSHolding(s) in Company
17th Oct 20087:00 amRNSInterim Management Statement
1st Sep 200812:00 pmRNSTotal Voting Rights
15th Aug 20086:29 pmRNSHolding(s) in Company
15th Aug 20086:15 pmRNSHolding(s) in Company
31st Jul 20084:14 pmRNSIssue of Equity
30th Jul 200812:24 pmRNSHolding(s) in Company
9th Jul 20087:00 amRNSAcquisition of Seal
1st Jul 20083:49 pmRNSHolding(s) in Company
24th Jun 20087:00 amRNSInterim Results
4th Jun 20087:00 amRNSTrading Statement
23rd May 20083:35 pmRNSHolding(s) in Company
19th May 20084:15 pmRNSDirector/PDMR Shareholding
19th May 200812:17 pmRNSDirector/PDMR Shareholding
29th Apr 20084:36 pmRNSHolding(s) in Company
9th Apr 20084:00 pmRNSResult of AGM
9th Apr 20087:00 amRNSAGM/Interim Management Stmt
1st Apr 20087:00 amRNSAcquisition
31st Mar 20088:00 amRNSTotal Voting Rights
26th Mar 20081:00 pmRNSAnnual Information Update
19th Mar 20087:00 amRNSBlocklisting Interim Review
11th Mar 20083:20 pmRNSFiling of Documents
5th Mar 20087:01 amRNSContract Wins
27th Feb 20087:01 amRNSParticipation in EU Project
29th Jan 20087:05 amRNSRe Agreement
29th Jan 20087:00 amRNSPreliminary Results
19th Dec 20074:46 pmRNSHolding(s) in Company
10th Dec 200711:56 amRNSHolding(s) in Company
10th Dec 20077:00 amRNSTrading Statement
2nd Oct 200711:35 amRNSLease of larger factory
2nd Oct 200711:27 amRNSDirectorate Change
2nd Oct 20078:44 amRNSDirector/PDMR Shareholding
31st Jul 20079:32 amRNSTotal Voting Rights
30th Jul 200711:00 amRNSDirector/PDMR Shareholding
26th Jun 20077:02 amRNSInterim Results
15th Jun 20078:00 amRNSAdditional Listing
6th Jun 20077:00 amRNSTrading Update
5th Jun 200711:28 amRNSAnnual Information Update
31st May 20071:10 pmRNSNotice of Results
18th Apr 20071:04 pmRNSResults of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.